-
1دورية أكاديمية
المؤلفون: Alain Vergnenegre, Margaux Geier, Florian Guisier, Regine Lamy, Bénédicte Comet, Gwenaelle Le Garff, Pascal Do, Henri Janicot, Hugues Morel, Chantal Decroisette, Michel Andre, Lionel Falchero, Nicolas Paleiron, Isabelle Monnet, the GFPC Team
المصدر: Cancer Medicine, Vol 9, Iss 2, Pp 432-439 (2020)
مصطلحات موضوعية: immune checkpoint inhibitors, non–small cell lung cancer, rapid progression, second‐line treatment, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2045-7634
-
2دورية أكاديمية
المؤلفون: Renaud Descourt, Maurice Pérol, Gaëlle Rousseau-Bussac, David Planchard, Bertrand Mennecier, Marie Wislez, Jacques Cadranel, Alexis Benjamin Cortot, Florian Guisier, Loïck Galland, Pascal Do, Roland Schott, Éric Dansin, Jennifer Arrondeau, Jean-Bernard Auliac, Margaux Geier, Christos Chouaïd
المصدر: Cancers, Vol 14, Iss 7, p 1751 (2022)
مصطلحات موضوعية: NSCLC, ALK rearrangment, brigatinib, lorlatinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Jean-Bernard Auliac, Sophie Bayle, Pascal Do, Gwenaëlle Le Garff, Magali Roa, Lionel Falchero, Eric Huchot, Gilles Quéré, Gaëlle Jeannin, Anne-Cécile Métivier, Joëlle Hobeika, Florian Guisier, Christos Chouaid
المصدر: Cancers, Vol 12, Iss 12, p 3608 (2020)
مصطلحات موضوعية: BRAF mutations, dabrafenib, non-small-cell lung cancer, oncogenic driver, targeted therapy, trametinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Jacques Cadranel, Alexis B. Cortot, Hervé Lena, Bertrand Mennecier, Pascal Do, Eric Dansin, Julien Mazieres, Christos Chouaid, Maurice Perol, Fabrice Barlesi, Gilles Robinet, Sylvie Friard, Luc Thiberville, Clarisse Audigier-Valette, Alain Vergnenegre, Virginie Westeel, Khemaies Slimane, Alexandru Buturuga, Denis Moro-Sibilot, Benjamin Besse
المصدر: ERJ Open Research, Vol 4, Iss 1 (2018)
مصطلحات موضوعية: Medicine
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Pascal Doguet, Jérôme Garnier, Aurore Nieuwenhuys, Carmen Godfraind, Yohan Botquin, Antoine Lemaire, John Justice, Antoine Nonclercq, Riëm El Tahry, Brian Corbett, Jean Delbeke
المصدر: Scientific Reports, Vol 14, Iss 1, Pp 1-19 (2024)
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2045-2322
-
6
المؤلفون: Hugues Morel, R. Lamy, Alain Vergnenegre, Gfpc Team, H. Janicot, Nicolas Paleiron, Isabelle Monnet, Michel Andre, Florian Guisier, Chantal Decroisette, Pascal Do, Bénédicte Comet, Lionel Falchero, Gwenaelle Le Garff, Margaux Geier
المصدر: Cancer Medicine
Cancer Medicine, Vol 9, Iss 2, Pp 432-439 (2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Multivariate analysis, Lung Neoplasms, Lymphocyte, medicine.medical_treatment, Disease, rapid progression, immune checkpoint inhibitors, 0302 clinical medicine, non–small cell lung cancer, Carcinoma, Non-Small-Cell Lung, Prospective Studies, Prospective cohort study, Original Research, Aged, 80 and over, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, Survival Rate, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Lymphatic Metastasis, Carcinoma, Squamous Cell, Disease Progression, Female, Adult, medicine.medical_specialty, Adenocarcinoma of Lung, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Lung cancer, Aged, Chemotherapy, Lung, business.industry, Clinical Cancer Research, second‐line treatment, medicine.disease, 030104 developmental biology, Tumor progression, Neoplasm Recurrence, Local, business, Follow-Up Studies
-
7
المؤلفون: Christos Chouaid, Jacques Letreut, Pascal Do, Pierre Alexandre Hauss, Lionel Falchero, Hélène Doubre, Jean-Bernard Auliac, Pascal Thomas, S. Bayle, F. Vinas
المساهمون: CH, Mantes-La-Jolie, Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Hospitalier Henri Duffaut (Avignon), Hôpital Foch [Suresnes], Université Paris-Est Créteil Val-de-Marne - Faculté de médecine (UPEC Médecine), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Européen [Fondation Ambroise Paré - Marseille], Hôpital Villefranche sur Saône, Hôpital Nord [CHU - APHM], Departement de chirurgie thoracique et des maladies de l'oesophage [Hôpital Nord - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital Nord [CHU - APHM], CIC - Biotherapie - CHU Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), IMRB - CEPIA/'Clinical Epidemiology And Ageing : Geriatrics, Primary Care and Public Health' [Créteil] (U955 Inserm - UPEC), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)
المصدر: Advances in Therapy
Advances in Therapy, 2019, 36 (8), pp.2161-2166. ⟨10.1007/s12325-019-01001-9⟩مصطلحات موضوعية: Adult, Male, Lung adenocarcinoma, Oncology, medicine.medical_specialty, Lung Neoplasms, Receptor, ErbB-2, medicine.medical_treatment, [SDV.CAN]Life Sciences [q-bio]/Cancer, Real life setting, Target therapy, Cohort Studies, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Pharmacology (medical), HER2 mutation, Lung cancer, Protein Kinase Inhibitors, Aged, Response rate (survey), Chemotherapy, Lung, Epidermal Growth Factor, business.industry, Brief Report, Receptor Protein-Tyrosine Kinases, General Medicine, Middle Aged, Prognosis, medicine.disease, Rheumatology, Management, medicine.anatomical_structure, Mutation, Cohort, Female, Non small cell, business
-
8دورية أكاديمية
المؤلفون: Jürgen Knapp, Pascal Doppmann, Markus Huber, Lorenz Meuli, Roland Albrecht, Stephen Sollid, Urs Pietsch
المصدر: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, Vol 31, Iss 1, Pp 1-9 (2023)
مصطلحات موضوعية: Prehospital emergency medicine, HEMS, Traumatic brain injury, Tracheal intubation, Ventilation, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1757-7241
-
9
المؤلفون: Marie Wislez, David Planchard, Eric Dansin, Christos Chouaid, Renaud Descourt, Loick Galland, Bertrand Mennecier, Roland Schott, Maurice Pérol, G. Rousseau-Bussac, Jean-Bernard Auliac, Jennifer Arrondeau, Florian Guisier, Alexis B. Cortot, Pascal Do
المساهمون: Equipe Quantification en Imagerie Fonctionnelle (QuantIF-LITIS), Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Université Le Havre Normandie (ULH), Normandie Université (NU)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Normandie Université (NU)
المصدر: Lung Cancer
Lung Cancer, Elsevier, 2019, 136, pp.109-114. ⟨10.1016/j.lungcan.2019.08.010⟩مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, Biopsy, [SDV]Life Sciences [q-bio], ALK rearrangement, Kaplan-Meier Estimate, ALK inhibitor, 0302 clinical medicine, Early access program, Carcinoma, Non-Small-Cell Lung, Clinical endpoint, Anaplastic Lymphoma Kinase, Aged, 80 and over, Gene Rearrangement, Middle Aged, 3. Good health, Treatment Outcome, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, medicine.drug, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, medicine.drug_class, Young Adult, 03 medical and health sciences, Organophosphorus Compounds, Crizotinib, Internal medicine, medicine, Humans, Lung cancer, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Retrospective Studies, Performance status, Ceritinib, business.industry, medicine.disease, Pyrimidines, 030104 developmental biology, Brigatinib, Advanced non-small cell lung cancer, business, Progressive disease
-
10
المؤلفون: Jaafar Bennouna, Denis Moro-Sibilot, Christos Chouaid, Pascal Do, Katell LeLay, Alain Vergnenegre, L. Luciani, Maurice Pérol, Gérard de Pouvourville
المصدر: Journal of Thoracic Oncology. 12:1496-1502
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Radiation-Sensitizing Agents, medicine.medical_specialty, Lung Neoplasms, Cost effectiveness, Cost-Benefit Analysis, Afatinib, Pharmacology, 03 medical and health sciences, 0302 clinical medicine, Gefitinib, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, 030212 general & internal medicine, health care economics and organizations, Survival analysis, Lung, business.industry, Cost-effectiveness analysis, respiratory tract diseases, medicine.anatomical_structure, Egfr mutation, 030220 oncology & carcinogenesis, Quinazolines, Non small cell, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b845699e5051be94f3977eed32aea94
https://doi.org/10.1016/j.jtho.2017.07.013